Formation Bio
@formationbio
Followers
2K
Following
87
Media
49
Statuses
124
AI-native pharma company, bringing new treatments to patients faster and more efficiently.
New York, NY
Joined November 2014
@IMIDomics discovered the initial science, and now.@formationbio is taking it forward to clinical development. Today we announced our license of IMIDomics' first-in-class, Phase-1 ready anti-CD226 antibody targeting Ulcerative Colitis. Go behind the scenes with both teams here.
0
4
13
Proud to see our Co-Founder & CEO @BenjamineYLiu on this list! If you're based in NYC, Boston, SF/Bay Area, or the Research Triangle (NC) and interested in joining our team -- check out our open roles: .
thegreatentrepreneurs.com
Great Entrepreneurs is pleased to announce The Top 25 HealthTech Entrepreneurs of New York for 2025. Based in one of the country’s most active centers for healthcare, life sciences, and venture-bac...
0
0
1
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
790
3K
10K
Great to see our transaction with @IMIDomics covered by @AndrewE_Dunn in @endpts. This is a promising step forward in autoimmune therapy for a patient population with high unmet need. Read more here!.
Exclusive: Formation Bio raised a $372M Series D last year. Later today, the New York biopharma will announce its first licensing deal since raising that money — bringing in a CD226 antibody from the Spanish biotech IMIDomics. My latest for @endpts:
0
1
5
RT @Techweek_: If you’re building for 10+ years, “just get started” won’t cut it. @BenjamineYLiu (CEO/cofounder of @formationbio ) says: a….
0
3
0
This morning we announced the license of gusacitinib, a dual JAK/SYK inhibitor, to Sanofi! We are excited that this transaction with Sanofi ushers gusacitinib into its next stage of development. You can read more here:.
prnewswire.com
/PRNewswire/ -- Formation Bio, an AI-native pharma company focused on accelerating drug development, today announced that its subsidiary Libertas Bio has...
0
0
2
The future of drug development is AI-native, and we're leading the charge. Hear more from our Co-Founder & CEO @BenjamineYLiu on @CNBC @CNBCFastMoney .
1
1
2
Excited to be named to @CNBCDisruptors 50 List this year. As AI disrupts every industry, we're proud to be leading the way for drug development.
0
3
3
Formation Bio welcomes our first class of Entrepreneurs in Residence! These dealmaking veterans will help drive pipeline growth, partnerships & BD strategy. Read more here:
0
1
4
RT @endpts: Exclusive: Ex-Pfizer CSO Mikael Dolsten joins Formation Bio to guide drug strategy — and shape how its AI makes R&D bets. https….
endpoints.news
Former Pfizer CSO Mikael Dolsten joins Formation Bio to lead drug-picking committee and help train AI systems, as startup aims to create AI version of veteran drug hunter's expertise.
0
1
0
Check out Part 2 of our blog series that goes "behind the scenes" of Muse, our GenAI-powered recruitment tool that streamlines patient recruitment for clinical trials.
0
0
3
At Formation Bio, we're building AI systems to accelerate and improve drug development. Our latest blog dives into Muse, our AI tool that transforms patient recruitment, creating recruitment strategy and materials in a matter of minutes.
0
2
5
Some highlights from Formation Bio CEO & Co-Founder @BenjamineYLiu at this morning's panel discussion at @wef about how companies - and entire industries - are positioned to scale with AI in unprecedented ways. You can find the full recording here:
0
0
4
Tune in tomorrow @wef as our Co-Founder & CEO @BenjamineYLiu discusses the future of AI-driven organizations, together with:.- @CNBC's @dan_murphy .- @imbue_ai's @kanjun .- @LeadEdgeCapital's Mitchell Green .- @LatticeHQ's Sarah Franklin .- @youdotcom's @RichardSocher.
0
0
4
We're delighted to have contributed to this white paper published today by @wef and @ZSAssociates exploring AI’s potential to revolutionize clinical development. The themes explored in this paper align deeply with our mission to harness AI for transformative advances in drug.
0
0
2
Our CDO @gavincorcoranmd will be presenting at @business's AI & Drug Development Forum next week in NYC! Learn more and register to attend here: Other presenters include: @OwkinScience @Certara @FlagshipPioneer @Clario @InSilicoMeds @Parexel.
go.bloomberg.com
0
4
3
RT @skupor: Great example of a tangible AI use case in one of the most intractable problem areas - drug development. Congrats @formationbio.
0
3
0
RT @AndrewE_Dunn: “If we think about all the drug development activities, we think there’s a Muse for everything,” Formation Bio CEO Benjam….
endpoints.news
A flashy collaboration between Sanofi, OpenAI and Formation Bio produced its first AI-powered tool, aiming to speed up the process of recruiting patients into clinical trials. The tool is called ...
0
7
0
RT @BenjamineYLiu: Meet Muse, our latest AI innovation for drug development—a tool designed to optimize patient recruitment built together….
0
15
0
